You are here

  • Home
  • Archive
  • Volume 82, Issue 6
  • Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al

Article info

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al

Authors

  • Kimme L Hyrich Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Martin Schäfer Epidemiology and Health Care Research, German Rheumatism Research Center Berlin (DRFZ Berlin), Berlin, Germany PubMed articlesGoogle scholar articles
  • Anja Strangfeld Epidemiology and Health Care Research, German Rheumatism Research Center Berlin (DRFZ Berlin), Berlin, Germany PubMed articlesGoogle scholar articles
  • Loreto Carmona Instituto de Salud Musculoesquelética, Madrid, Spain PubMed articlesGoogle scholar articles
  • Laure Gossec Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Université, Paris, France Department of Rheumatology, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Elsa F Mateus Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), European Alliance of Associations for Rheumatology (EULAR), Kilchberg, Switzerland PubMed articlesGoogle scholar articles
  • Saskia Lawson-Tovey Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Milena Gianfrancesco Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Philip C Robinson Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia Metro North Hospital & Health Service, Royal Brisbane and Woman's Hospital Health Service District, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Jinoos Yazdany Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Pedro M Machado Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Pedro M Machado, Centre for Rheumatology, University College London, London, UK; p.machado{at}ucl.ac.uk
View Full Text

Citation

Hyrich KL, Schäfer M, Strangfeld A, et al
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al
Annals of the Rheumatic Diseases 2023;82:e139.

Publication history

  • Received May 2, 2021
  • Accepted May 4, 2021
  • First published May 13, 2021.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage